Hong Zhang - Health Discovery Sr. VP of Computational Medicine

SVP

Dr. Hong Zhang, Ph.D., is Senior Vice President Computational Medicine of Health Discovery Corporationrationration. As visiting faculty at Johns Hopkins University, Dr. Zhang lectured at the Center for Biomarker Discovery on Bioinformatics Peak Detection Methods for Mass Spectral Data. Currently a Yamacraw Associate Professor at Armstrong Atlantic University, Dr. Zhang was the Vice President and CIO for a neural network and computer assisted medical diagnostic systems company that employs neural network and mathematicalstatistical preprocessing techniques. In this position, Dr. Zhang was involved in digital image processing and pattern recognition for medical image processing as well as software design and programming for support vector machine applications. Dr. Zhang was a professor in the Department of Mathematical Sciences at Purdue University from 1989 to 1996. He has held numerous academic positions, including Adjunct Associate Professor, Associate Professor with Tenure, and Assistant Professor. He was a visiting Associate Professor in 1995 in the Department of Biometry at the Medical University of South Carolina. since 2004.
Age 59
Tenure 21 years
Phone404 566 4865
Webhttps://www.healthdiscoverycorp.com

Health Discovery Management Efficiency

The company has return on total asset (ROA) of (1.722) % which means that it has lost $1.722 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (38.3421) %, meaning that it created substantial loss on money invested by shareholders. Health Discovery's management efficiency ratios could be used to measure how well Health Discovery manages its routine affairs as well as how well it operates its assets and liabilities.
Health Discovery Cp currently holds 212 K in liabilities with Debt to Equity (D/E) ratio of 0.56, which is about average as compared to similar companies. Health Discovery has a current ratio of 0.32, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Health Discovery until it has trouble settling it off, either with new capital or with free cash flow. So, Health Discovery's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Health Discovery sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Health to invest in growth at high rates of return. When we think about Health Discovery's use of debt, we should always consider it together with cash and equity.
Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United States. The company was incorporated in 2001 and is based in Atlanta, Georgia. Health Discovery operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 3 people. Health Discovery Cp [HDVY] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Health Discovery Management Team

Elected by the shareholders, the Health Discovery's board of directors comprises two types of representatives: Health Discovery inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Health. The board's role is to monitor Health Discovery's management team and ensure that shareholders' interests are well served. Health Discovery's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Health Discovery's outside directors are responsible for providing unbiased perspectives on the board's policies.
George III, Chairman CEO
Hong Zhang, Sr. VP of Computational Medicine
Mark Moore, VP of Product Devel.

Health Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Health Discovery a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Health Pink Sheet Analysis

When running Health Discovery's price analysis, check to measure Health Discovery's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Discovery is operating at the current time. Most of Health Discovery's value examination focuses on studying past and present price action to predict the probability of Health Discovery's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Discovery's price. Additionally, you may evaluate how the addition of Health Discovery to your portfolios can decrease your overall portfolio volatility.